Guillou L, Coindre J M, Bonichon F, Nguyen B B, Terrier P, Collin F, Vilain M O, Mandard A M, Le Doussal V, Leroux A, Jacquemier J, Duplay H, Sastre-Garau X, Costa J
University Institute of Pathology, Lausanne, Switzerland.
J Clin Oncol. 1997 Jan;15(1):350-62. doi: 10.1200/JCO.1997.15.1.350.
Several histologic grading systems have been validated in soft tissue sarcomas (STS), but no system is currently accepted worldwide. The National Cancer Institute (NCI) and French Federation of Cancer Centers Sarcoma Group (FNCLCC) systems were examined comparatively in the same population of patients with STS to determine which system is the best prognosticator with regard to metastasis development and tumor mortality.
Four hundred ten adult patients with nonmetastatic STS were examined. Histologic grade was established according to the NCI and FNCLCC systems in each case. The prognostic value of both systems was examined using univariate and multivariate (Cox's model) analyses, and special attention was devoted to tumors with discordant grades.
In univariate analysis, both the NCI and FNCLCC systems were of prognostic value to predict metastasis development and tumor mortality. In multivariate analysis, high-grade tumors, irrespective of the system used, size > or = 10 cm, and deep location were found to be independent prognostic factors for the advent of metastases. Tumor grade had a higher predictive value than size or depth, and higher prognostic weight was assigned to the FNCLCC grading system in Cox models. Grade discrepancies were observed in 34.6% of the cases. An increased number of grade 3 STS, a reduced number of grade 2 STS, and a better correlation with overall and metastasis-free survival within subpopulations with discordant grades were observed in favor of the FNCLCC system.
The FNCLCC system showed slightly increased ability to predict distant metastasis development and tumor mortality. The use of this system to evaluate STS aggressiveness might be favored.
几种组织学分级系统已在软组织肉瘤(STS)中得到验证,但目前尚无一种系统被全球广泛接受。本研究在同一组STS患者中对美国国立癌症研究所(NCI)和法国癌症中心肉瘤研究组(FNCLCC)的系统进行了比较,以确定哪种系统在转移发生和肿瘤死亡率方面是最佳的预后指标。
对410例成年非转移性STS患者进行了检查。每例均根据NCI和FNCLCC系统确定组织学分级。使用单因素和多因素(Cox模型)分析来检验这两种系统的预后价值,并特别关注分级不一致的肿瘤。
在单因素分析中,NCI和FNCLCC系统在预测转移发生和肿瘤死亡率方面均具有预后价值。在多因素分析中,无论使用哪种系统,高级别肿瘤、大小≥10 cm以及深部位置被发现是转移发生的独立预后因素。肿瘤分级比大小或深度具有更高的预测价值,并且在Cox模型中FNCLCC分级系统被赋予了更高的预后权重。在34.6%的病例中观察到分级差异。支持FNCLCC系统的方面包括3级STS数量增加、2级STS数量减少,以及在分级不一致的亚组中与总生存和无转移生存具有更好的相关性。
FNCLCC系统在预测远处转移发生和肿瘤死亡率方面显示出略有增强的能力。使用该系统评估STS的侵袭性可能更具优势。